| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.22 | 0.0004 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0007 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.16 | 0.0008 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |